Prasol Chemicals IPO subscription
Analysis based on 13 articles · First reported Sep 03, 2026 · Last updated Sep 09, 2026
The IPO is expected to raise Rs 500 crore for Prasol Chemicals Limited, aiding debt repayment and general corporate purposes, while providing an exit for existing shareholders. The listing on BSE and NSE will increase the company's visibility and provide liquidity, with brokerages viewing the issue positively due to strong financials and market positioning.
Prasol Chemicals Limited Ltd., an Indian specialty chemicals manufacturer, launched its initial public offering (IPO) on September 8, 2026. The book-built issue of Rs 500 crore comprises a fresh issue of 11.83 lakh shares (Rs 80 crore) and an offer for sale of 62.13 lakh shares (Rs 420 crore) by existing promoters and selling shareholders. The price band was set at Rs 643-676 per share, with a lot size of 22 shares. The subscription window runs from September 8 to September 10, with allotment expected on September 11 and listing tentatively on September 16 on both the BSE and NSE. The company plans to use Rs 60 crore of the fresh issue proceeds to repay debt. The IPO received a modest response, with subscription reaching 0.13-0.41 times on the first day, and grey market premium ranging from Rs 30 to Rs 55. Several brokerages, including State Bank of India — SBI Securities, Meritz Securities, and Anand Rathi, recommended subscribing, citing the company's strong financial performance and niche market position as the sole Indian manufacturer of isophorone. Prasol Chemicals Limited reported FY26 revenue of Rs 1,237.85 crore and profit after tax of Rs 83.12 crore, reflecting strong growth.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard